Dermatologic Disorders

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The US Food and Drug Administration has approved a new medication therapy for the treatment of metastatic and unresectable melanoma.

A prescription is no longer needed to obtain the topical lotion for treating head lice. This comes in response to the millions of cases of head lice reported annually by the Centers for Disease Control and...

The FDA has warned that the antipsychotic drug, olanzapine, may be associated with a rare but serious skin reaction.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

The FDA has approved new options for hidradenitis suppurativa and hereditary orotic acuduria.

The FDA has approved new options for basal cell carcinoma, HIV diagnosis, and high cholesterol that clinicians should be aware of.

The FDA has warned of the possibility of serious and sometimes fatal skin reactions associated with an antipsychotic used to treat schizophrenia and bipolar disorder.